Epidemiology of peptic ulcer disease in cirrhotic patients: Role of Helicobacter pylori infection

American Journal of Gastroenterology

Volumn 93, Issue 12, 1998, Pages 2501-2507

  Calvet, X ^a,b   Navarro, M ^a   Gil, M ^a   Lafont, A ^a   Sanfeliu, I ^a   Brullet, E ^a   Campo, R ^a   Dalmau, B ^a   Rivero, E ^a   Mas, P ^a  

^a CatLab   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G;

ADULT; ARTICLE; BACTERIAL INFECTION; COMORBIDITY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS VARICES; FEMALE; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER PYLORI; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SERODIAGNOSIS; SEX DIFFERENCE;

FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PEPTIC ULCER; PREVALENCE; SEX DISTRIBUTION;

EID: 0032434464     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.00711.x     Document Type: Article

References (53)

1. 1. Marshall BJ, Goodwin CS, Warren JR, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988;2:1437-42.
2. 2. Coghlan JG, Gilligan D, Humphries H, et al. Campylobacter pylori and recurrence of duodenal ulcers - a 12-month follow-up study. Lancet 1987;2:1109-11.
3. 3. George LL, Borody TJ, Andrews P, et al. Cure of duodenal ulcer after eradication of Helicobacter pylori. Med J Aust 1990;153:145-9.
4. 4. Graham DY. Helicobacter pylori: Its epidemiology and its role in duodenal ulcer disease. J Gastroenterol Hepatol 1991;6:105-13.
5. 5. Hentschel E, Brandstatter G, Dragosics B, et al. Effect of ranitidine and amoxyciline plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993;328: 308-12.
6. 6. Siringo S, Burroughs AK, Bolondi L, et al. Peptic ulcer and its course in cirrhosis: An endoscopic and clinical prospective study. J Hepatol 1995;22:633-41.
7. 7. Chen JJ, Changchien ChS, Tai DA, et al. Role of Helicobacter pylori in cirrhotic patients with peptic ulcer. A serological study. Dig Dis Sci 1994;39:1565-8.
8. 8. Wu ChS, Lin Ch-Y, Liaw YF. Helicobacter pylori in cirrhotic patiens with peptic ulcer disease: A prospective, case controlled study. Gastrointest Endosc 1995;42:424-7.
9. 9. Siringo S, Vaira B, Bolondi L, et al. High prevalence of Helicobacter pylori in liver cirrhosis: Relationship with clinical and endoscopic features and the risk of peptic ulcer. Dig Dis Sci 1997;42:2024-30.
10. 10. Gil M, Lafon A, Rue M, et al. Influencia del consejo dietético sobre el estado nutricional y la evolución de los pacientes con cirrosis hepática. Gastroenterol Hepatol 1996;19:S1:51 (abstract).
11. 11. Pugh RNH, Murray-Lyon IM, Dawson JL, et al. Transection of the esophagus for bleeding esophageal varices. Br J Surg 1973;60:646-64.
12. 12. Calvet X, Navarro M, Gil M, et al. Seroprevalence and epidemiology of Helicobacter pylori infection in cirrhotic patients. J Hepatol 1997; 26:1249-54.
13. 13. Brullet E, Calvet X, Campo R, et al. Factors predicting failure of endoscopic injection therapy in bleeding duodenal ulcer. Gastrointest Endosc 1996;43:111-6.
14. 14. Brullet E, Campo R, Calvet X, et al. Factors related to the failure of endoscopic therapy for bleeding gastric ulcer. Gut 1996;39:155-8.
15. 15. Martin TR, Vennes JA, Silvis SE, et al. A comparison of upper gastrointestinal endoscopy and radiology. J Clin Gastroenterol 1980; 2:21-5.
16. 16. Talley NJ, Kost L, Haddad A, et al. Comparison of commercial serological tests for detection of Helicobacter pylori antibodies. J Clin Microbiol 1992;30:3146-50.
17. 17. Navarro F, Coll P, Sainz S, et al. Evaluación de dos preparados comerciales para la detección de anticuerpos específicos de Helicobacter pylori en pacientes sometidos a gastroscopia. Estudio de la seroprevalencia en la población asintomática. Enf Infec Microbiol Clin 1992;10:190-4.
18. 18. Cutler AF, Havstad S, Ma ChK, et al. Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology 1995;109:136-41.
19. 19. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley & Sons, 1989.
20. 20. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143: 29-36.
21. 21. Tabaqchali S, Dawson AM. Peptic ulcer and gastric secretion in patient with liver disease. Gut 1964;5:417-21.
22. 22. Phillips MM, Ramsby GR, Conn HO. Portocaval anastomosis and peptic ulcer: A nonassociation. Gastroenterology 1975;68:121-31.
23. 23. Kirk AP, Dooley JS, Hunt RH. Peptic ulceration in patients with chronic liver disease. Dig Dis Sci 1980;25:756-60.
24. 24. Sacchetti C, Capello M, Rebecchi P, et al. Frequency of upper gastrointestinal lesions in patients with liver cirrhosis. Dig Dis Sci 1988; 33:1218-22.
25. 25. De Weert TM, Gostout CJ, Wiesner RH. Congestive gastropathy and other upper endoscopic findings in 81 consecutive patients undergoing orthotopic liver transplantation. Am J Gastroenterol 1990;85:573-6.
26. 26. Rabinovitz M, Kumar S, Kajani M, et al. Combined upper and lower gastrointestinal endoscopy: A prospective study in alcoholic and non-alcoholic cirrhosis. Alcoholism Clin Exp Res 1989;13:790-4.
27. 27. Rabinovitz M, Yoo Y-K, Schade RR, et al. Prevalence of endoscopic findings in 510 consecutive individuals with cirrhosis evaluated prospectively. Dig Dis Sci 1990;35:705-10.
28. 28. Rabinovitz M, Schade RR, Dindzans VJ, et al. Prevalence of duodenal ulcer in cirrhotic males referred for liver transplantation - does the etiology of cirrhosis make a difference? Dig Dis Sci 1990;35:321-6.
29. 29. Bonnevie O. The incidence of duodenal ulcer in Copenhagen County. Scand J Gastroenterol 1975;10:385-93.
30. 30. Bonnevie O. The incidence of gastric ulcer in Copenhagen County. Scand J Gastroenterol 1975;10:231-9.
31. 31. Wormsley KG. Association between duodenal ulcer and other diseases. Scand J Gastroenterol 1980;15 (suppl 63):27-35.
32. 32. Ihamaki T, Varis K, Siurala M. Morphological, functional and immunological state of the gastric mucosa in gastric carcinoma families. Comparison with a computer-matched family sample. Scand J Gastroenterol 1979;14:801-12.
33. 33. Kaneko E, Ooi S, Ito G, et al. Natural history of duodenal ulcer detected by the gastric mass surveys in men over 40 years of age. Scand J Gastroenterol 1989;24:165-70.
34. 34. Kurata JH, Nogawa AN, Abbey DE, et al. A prospective study of risk for peptic ulcer disease in Seventh-day Adventists. Gastroenterology 1992;102:902-9.
35. 35. Kurata JH, Helashoff JD, Nogawa AN, et al. Sex and smoking differences in duodenal ulcer mortality. Am J Public Health 1986;76:700.
36. 36. Kurata JH, Haile BM, Elashoff JD. Sex differences in peptic ulcer disease. Gastroenterology 1985;88:96-100.
37. 37. Friendman GD, Siegelaub AB, Seltzer CC. Cigarettes, alcohol, coffee and peptic ulcer. N Engl J Med 1974;290:469-73.
38. 38. Lam SK. Hypergastrinaemia in cirrhosis of liver. Gut 1976;17:700.
39. 39. Lenz HJ, Struck T, Greten H, et al. Increased sensitivity of acid gastric secretion to gastrin in cirrhotic patients with porta-caval shunt. J Clin Invest 1987;79:1120-4.
40. 40. Arakawa T, Satoh H, Fukuda T, et al. Endogenous prostaglandin E2 in gastric mucosa of patients with alcoholic cirrhosis and portal hypertension. Gastroenterology 1987;93:135-40.
41. 41. Weiler H, Weiler C, Gerok W. Gastric mucosal prostaglandin E2 levels in cirrhosis and portal hypertension. J Hepatol 1990;11:58-64.
42. 42. Taha AS, Reid J, Boothmann P, et al. Serological diagnosis Helicobacter pylori - evaluation of four tests in the presence or absence of non-steroidal anti-inflammatory drugs. Gut 1993;34:461-5.
43. 43. Cullen DJE, Collins BJ, Christiansen KJ, et al. When is Helicobacter pylori infection acquired? Gut 1993;34:1681-2.
44. 44. The EUROGAST Study Group. Epidemiology of, and risk factors for Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. Gut 1993;34:1672-6.
45. 45. Teh BH, Lin JT, Pan SH, et al. Seroprevalence and associated risk factors of Helicobacter pylori infection in Taiwan. Anticancer Research 1994;14:1389-92.
46. 46. Mendall MA, Goggin PM, Molineaux N, et al. Childhood living conditions and Helicobacter pylori seropositivity in adult life. Lancet 1992;339:896-7.
47. 47. Patel P, Mendall MA, Khulusi S, et al. Helicobacter pylori infection in childhood: Risk factors and effect on growth. Br Med J 1994;309: 1119-23.
48. 48. Klein PD, Graham DY, Gaillour A, et al. Water source as risk factor for Helicobacter pylori infection in Peruvian children. Lancet 1991,337:1503-6.
49. 49. Carballo F, Martinez, Aldeguer M, et al. Infección por Helicobacter pylori en Guadalajara: prevalencia y factores asociados. Rev Esp Enf Dig 1995;87 (suppl 1):7 (abstract).
50. 50. Rimola A. Infections in liver disease. In: McIntyre N, Benhamou JP, Bircher J, et al., eds. Oxford textbook of clinical hepatology. Oxford: Oxford University Press, 1991:791-809.
51. 51. Salaspuro, M. Epidemiological aspects of alcohol and alcoholic liver disease, ethanol metabolism, and pathogenesis of alcoholic liver injury. In: McIntyre N, Benhamou JP, Bircher J, et al., eds. Oxford textbook of clinical hepatology. Oxford: Oxford University Press, 1991:791-809.
52. 52. Bonnevie O. Causes of death in duodenal and gastric ulcer. Gastroenterology 1977;73:1000-4.
53. 53. Graham DY, Hepps KS, Ramirez FC, et al. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease. Scand J Gastroenterol. 1993;28:939-42.